Alphatec Holdings, Inc. (ATEC)
NASDAQ: ATEC · Real-Time Price · USD
20.97
+0.20 (0.94%)
At close: Dec 26, 2025, 4:00 PM EST
21.37
+0.40 (1.92%)
After-hours: Dec 26, 2025, 6:17 PM EST
Alphatec Holdings Market Cap
Alphatec Holdings has a market cap or net worth of $3.11 billion as of December 26, 2025. Its market cap has increased by 127.64% in one year.
Market Cap
3.11B
Enterprise Value
3.55B
1-Year Change
127.64%
Ranking
Category
Stock Price
$20.97
Market Cap Chart
Since June 12, 2006, Alphatec Holdings's market cap has increased from $280.10M to $3.11B, an increase of 1,011.87%. That is a compound annual growth rate of 13.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 3.11B | 139.31% |
| Dec 31, 2024 | 1.30B | -36.81% |
| Dec 29, 2023 | 2.06B | 58.73% |
| Dec 30, 2022 | 1.30B | 14.33% |
| Dec 31, 2021 | 1.13B | -0.33% |
| Dec 31, 2020 | 1.14B | 161.53% |
| Dec 31, 2019 | 435.40M | 339.80% |
| Dec 31, 2018 | 99.00M | 122.47% |
| Dec 29, 2017 | 44.50M | 55.59% |
| Dec 30, 2016 | 28.60M | -5.61% |
| Dec 31, 2015 | 30.30M | -78.12% |
| Dec 31, 2014 | 138.50M | -29.37% |
| Dec 31, 2013 | 196.10M | 30.91% |
| Dec 31, 2012 | 149.80M | -2.41% |
| Dec 30, 2011 | 153.50M | -35.80% |
| Dec 31, 2010 | 239.10M | -14.76% |
| Dec 31, 2009 | 280.50M | 151.80% |
| Dec 31, 2008 | 111.40M | -53.17% |
| Dec 31, 2007 | 237.90M | 83.28% |
| Dec 29, 2006 | 129.80M | -53.66% |
| Jun 12, 2006 | 280.10M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |